Dermatomyositis and polymyositis (myositis) trials in Slovakia

2 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  Where

  Piešťany

  Age

  18 years and over

  People

  240 worldwide

  Run by

  argenx

  See details and how to joinNCT05979441 · EU 2022-502851-79-00
• Phase 3Taking people
  A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  Where

  Piešťany

  Age

  18 years and over

  People

  318 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05895786 · EU 2022-502739-20-00